Dividend-adjusted total return · S&P 500 uses VOO · Oct 7, 2026 – Nov 5, 2026FMEDS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | −6.5% | −0.2% | +3.7% | +14.6% | +19.1% | +53.6% | — | +23.2% |
| Peer average | −5.0% | −7.8% | −6.0% | +4.0% | +3.8% | +81.0% | +11.0% | — |
| S&P 500 · VOO | −4.4% | −5.7% | −4.9% | +8.4% | +9.8% | +82.2% | +71.6% | — |
Key Statistics
Open all fund facts →- AUM
- $52M
- Expense ratio
- 0.50%
- Distribution yield
- 0.0%
- NAV
- $33.13
- Volume
- 635K
- Avg. volume 30D
- 32K
- High today
- $33.13
- Low today
- $30.99
- Previous close
- $33.14
- 52-week high
- $33.56
- 52-week low
- $23.48
- Our risk indicator
- 4/5
FMED in One Breath
FMED Among Disruptive Tech ETFs
YTDEnd-of-day Nov 5, 2026 · 25 Disruptive tech ETFs by YTD
$10,000 in FMED
5Y$10,000 in FMED became
$12,317
In the S&P 500 (VOO)
$17,698
Total return, dividends in · Jun 12, 2023 – Nov 5, 2026 · S&P 500 uses VOO
FMED’s Top Holdings
TodayTXG10x Genomics4.2%TMO4.1%NTRA4.0%DHR3.8%LFST3.1%ARGX2.9%ILMN2.8%MRNA2.8%DIM.PA2.7%RVMD2.6%KNSA2.4%ISRG2.3%HTFL2.3%WST2.3%KYMR2.2%COGT2.1%UCB.BR2.0%PCVX2.0%GH2.0%ASND1.9%VRDN1.7%41 more
BiotechnologyMedical - DiagnosticsMedical - InstrumentsMedical - Healthcare Information ServicesMedical - Care FacilitiesOther
Fidelity FMED · 63 holdings · tile size = share of the fund · as of Nov 5, 2026
What FMED Holds
TodayBiotechnology48.1%
TXG 4.2 · ARGX 2.9 · MRNA 2.8 · RVMD 2.6 · KYMR 2.2 · COGT 2.1 · UCB.BR 2.0
Medical - Diagnostics & Research17.7%
TMO 4.1 · NTRA 4.0 · DHR 3.8 · ILMN 2.8 · GH 2.0 · VCYT 1.1
Medical - Instruments & Supplies10.4%
DIM.PA 2.7 · ISRG 2.3 · WST 2.3 · RGEN 1.7 · KMTS 1.3
Medical - Devices5.3%
EW 1.6 · BRKR 1.2 · BSX 1.0 · IRTC · DXCM
Medical - Healthcare Information Services4.8%
HTFL 2.3 · BTSG 1.2 · WAY 1.2
Medical - Care Facilities3.1%
LFST 3.1
Medical - Pharmaceuticals2.4%
KNSA 2.4
Fidelity FMED · share of the fund by industry · as of Nov 5, 2026
10x’s Share of FMED
Today4.2%
$42 of every $1,000 in FMED is 10x
10x held by FMED
$2.2M
Fidelity FMED · each square = $10 of $1,000 · as of Nov 5, 2026
FMED’s Share of Disruptive Tech ETFs
Today0.1%
of the $50.6B in 26 Disruptive tech ETFs
$52.3M0.1%
$13.0B25.6%
$11.6B22.9%
$26.0B51.3%
Disruptive tech ETF AUM · Nov 5, 2026
FMED Fee per $100 vs Peers
TodayExpense ratio · Disruptive tech peers · Nov 5, 2026
Inside FMED
63 holdings · as of Nov 5, 2026FMED
Fidelity Disruptive Medicine ETF
TodayBiotechnology48.1%TXG4.2%ARGX2.9%MRNA2.8%RVMD2.6%KYMR2.2%COGT2.1%UCB.BR2.0%PCVX2.0%ASND1.9%VRDN1.7%INSM1.5%ALNYTWSTAMLX26 more holdings18.0% of the fundMedical - Diagnostics17.7%TMO4.1%NTRA4.0%DHR3.8%ILMN2.8%GHMedical - Instruments10.4%DIM.PAISRGWSTRGENKMTSMedical - Devices5.3%EWBRKRBSXIRTCMedical - Healthcare Information Services4.8%HTFL2.3%BTSGWAYMedical - Care Facilities3.1%LFSTMedical - Pharmaceuticals2.4%KNSASoftware - Application1.7%VEEVMedical - Healthcare Plans1.7%UNHLLYOther3.9%CTMXBRVE
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | TXG | 10X Genomics | 4.23% |
| 2 | TMO | Thermo Fisher Scientific | 4.08% |
| 3 | NTRA | Natera | 3.95% |
| 4 | DHR | Danaher | 3.81% |
| 5 | LFST | Lifestance Health Group | 3.13% |
| 6 | ARGX | Argenx SE Sponsored | 2.87% |
| 7 | ILMN | Illumina | 2.78% |
| 8 | MRNA | Moderna | 2.76% |
| 9 | DIM.PA | Sartorius Stedim Biotech | 2.72% |
| 10 | RVMD | Revolution Medicines | 2.59% |
BiotechnologyMedical - DiagnosticsMedical - InstrumentsMedical - DevicesMedical - Healthcare Information ServicesMedical - Care FacilitiesMedical - PharmaceuticalsSoftware - ApplicationMedical - Healthcare PlansDrug Manufacturers - GeneralOther
Fidelity FMED · current holdings by weight · as of Nov 5, 2026 · each tile is one holding · top 20 = 54.4%
How It Compares
FMED
Fidelity Disruptive Medicine ETF’s Peers
YTDDisruptive tech peers · YTD and past-year returns · as of Nov 6, 2026 · sorted by AUM
Head to Head
Put FMED head to head with IGV →IGV vs FMED
YTDYear to date
FMED wins+20.9 pts
Past year
FMED wins+30.7 pts
Fee
IGV winslower fee
Yield
Level
AUM
IGV248.2× more
2–1FMED wins
iShares IGV and Fidelity FMED · year-to-date · as of Nov 6, 2026 · AUM not scored
Disruptive Tech vs Thematic
Average · YTDIGV
−6.3%
FMED
+14.6%
Thematic average
+2.3%
IGV, FMED and the average thematic ETF · YTD return · as of Nov 6, 2026
FMED vs VOO
YTDFMED · Fidelity Disruptive Medicine
+14.6%
VOO · S&P 500
+8.4%
Gap
6.2 pts
Fidelity FMED and Vanguard VOO · YTD total return · as of Nov 6, 2026
FMED vs Its Peer Average
YTDFMEDAvsBPeer average
1D−6.5%−5.0%
1M−0.2%−7.8%
3M+3.7%−6.0%
YTD+14.6%+4.0%
1Y+19.1%+3.8%
3Y+53.6%+81.0%
5Y[…]+11.0%
4–2FMED wins
25 Disruptive tech peers · each row scaled to its leader
The Details
FMED
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y24.59%
Deepest drop · 1Y−18.3%
Lowest point · 5Y−19.6%
52-week range
$30.99
$23.48−7.7% from the high$33.56
Fidelity FMED · past-year price moves · as of Nov 6, 2026
FMED
Fund Facts
Today2020launched Apr 16
Tracks[…]
Exchange · CUSIPNASDAQ · 316092147
StructureETF
Leverage1x
Cost on $10,000$50 a year
Go deeper
Fidelity FMED · fund facts · as of Nov 6, 2026
FMED
Payouts by Year
1Y$0.11per share, Dec 2024
Distribution yield0.0%
Paid[…]
Latest ex-date · paidDec 20 · Dec 24, 2024
2 payouts added up$0.11 a share
Fidelity FMED · distributions by ex-date · 2024–2024
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-08-31 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-05-31 ↗SEC reported portfolio · 2026-02-28 ↗SEC reported portfolio · 2025-11-30 ↗SEC reported portfolio · 2025-08-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-05-31 ↗SEC reported portfolio · 2025-02-28 ↗SEC reported portfolio · 2024-11-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-08-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-05-31 ↗SEC reported portfolio · 2024-02-29 ↗
Trading & Liquidity
Net asset value$33.13
Premium / discount[…]
Median spread · 30D[…]
Volume today635K
Average volume · 30D32K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.50%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$50.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 20, 2024 | Dec 24, 2024 | $0.11 |
| Jun 21, 2024 | Jun 25, 2024 | $0.0010 |
Issuer contentFrom FidelityHear the strategy from the people behind FMED.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →